Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,623 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07642765Recruiting
Frailty Score and Blood Pressure Changes During Surgery
This study looks at a simple scoring system (EASIX) that predicts whether older or frail patients will experience dangerous blood pressure drops when anesthesia is given before surgery. Understanding this risk might help doctors better protect vulnerable patients during their operations.
KonyaAges 18 years+ - NCT07640997Recruiting
Real-world study of aflibercept for age-related macular degeneration
This study follows patients receiving aflibercept 8 mg injections in the eye to treat wet age-related macular degeneration (nAMD), a condition that blurs central vision. The goal is to understand how well this treatment works and its safety in routine medical practice.
Beijing, Beijing MunicipalityAges 50 years+ - NCT02446431RecruitingEarly Phase 1
Low-dose cancer medicine for children with sarcoma at high risk
This early-phase study tests a continuous, low-dose (“metronomic”) cancer medicine to help delay cancer coming back in children and young adults with certain sarcomas. You must have finished first-line treatment and currently be in remission, starting the study soon after treatment ends.
Long Beach, CaliforniaAges 1–31 - NCT06766266RecruitingPhase 1
Irinotecan and Epirubicin for recurring bladder cancer
This trial tests a combination of two chemotherapy drugs (irinotecan and epirubicin) for people whose bladder cancer has come back after prior treatment with a similar drug. The goal is to see if this combination can help shrink or control the cancer.
ChongqingAges 18 years+ - NCT03660917RecruitingPhase 2/Phase 3
Riluzole treatment for SCA7 nerve balance problems
This trial studies whether riluzole can help people with spinocerebellar ataxia type 7 (SCA7), a genetic condition that affects balance and coordination. It may help slow symptoms or improve daily function, and you’d be closely monitored for side effects.
RomeAges 7 years+ - NCT07636525Recruiting
Sleep and Teen Vaccine Response Study
This study looks at how sleep affects how well a meningococcal vaccine works in 11–12 year olds. Researchers want to understand if getting good sleep helps your body respond better to vaccines.
Cincinnati, OhioAges 11–12 - NCT06081907RecruitingPhase 1/Phase 2
IBI363 for advanced solid tumors
This trial tests a new drug called IBI363 for people with advanced solid tumors, focusing on lung cancer and melanoma. It aims to see if the drug is safe and effective, especially for those whose previous treatments have stopped working.
Changsha, HunanAges 18–75 - NCT07631624Recruiting
Blood test for lung cancer screening in smokers and former smokers
This study tests whether a simple blood test that detects smoking-related changes in DNA can help identify who should get lung cancer screening. Researchers want to see if this test is better at finding people at risk than current methods.
Antwerp, AntwerpenAges 50 years+ - NCT02366221Enrolling by invitation
Study of long-term outcomes after complex arm or leg injuries
This study looks at how people do long-term after complex injuries to the arm or leg, after their usual care is finished. It may help doctors understand what outcomes to expect and improve future treatment planning.
Ages 18 years+ - NCT07626489Recruiting
Numbing injection to reduce pain after lung surgery
This trial tests whether injecting a numbing medication (ropivacaine) mixed with a steroid (Diprospan) into the surgical area before chest surgery can reduce pain after the procedure. If it works, patients may need fewer pain pills and feel more comfortable during recovery.
Beijing, Beijing MunicipalityAges 18–64 - NCT07405346Enrolling by invitation
Organoid-guided treatment for advanced leiomyosarcoma
This trial uses your tumor's lab-grown organoids to find the most effective personalized treatment for advanced leiomyosarcoma. It aims to match you with a drug that targets your specific cancer.
Wuhan, HubeiAges 18–75 - NCT07281157RecruitingPhase 2
Liposomal irinotecan, capecitabine and enlonstobart with short radiation for rectal cancer
This trial tests a combination of short-course radiation, two chemotherapy drugs (liposomal irinotecan and capecitabine), and an immunotherapy drug (Enlonstobart) for people with locally advanced rectal cancer. The goal is to see if this approach can shrink the tumor before surgery.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT03438526RecruitingPhase 4
Melatonin treatment for low-activity delirium in ICU patients
This trial tests whether giving melatonin (or a placebo) can help adults in the intensive care unit who have a specific type of confusion called low-activity delirium. It aims to improve recovery by supporting sleep–wake regulation in the ICU.
BaselAges 55 years+ - NCT07608094Recruiting
Cesarean Scar Pregnancy Treatment Outcomes Study
This study looks at the best ways to treat cesarean scar pregnancies—a rare condition where a pregnancy develops in the scar tissue from a previous cesarean delivery. Researchers will track how different treatments work and help improve care for women with this condition.
Hangzhou, ZhejiangAges 18 years+ - NCT06791460RecruitingPhase 2/Phase 3
A study of two drug combinations for ovarian cancer that came back
This trial tests a common chemotherapy (Pegylated Liposomal Doxorubicin) plus an immunotherapy (Adebrelimab), with or without a bladder medication (Mirabegron), in people whose ovarian cancer has returned after initial treatment. The goal is to see if adding Mirabegron helps the other drugs work better.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07079865Recruiting
Nerve stimulation for pain after spine fracture
This trial tests a 60-day nerve stimulation treatment to reduce pain and improve mobility after a recent spine fracture caused by osteoporosis. It may help patients who still have significant pain despite over-the-counter pain relievers.
Avenel, New JerseyAges 18 years+ - NCT06876688RecruitingPhase 2
Relma-cel and Tislelizumab for CNS Lymphoma
This trial tests a combination of two drugs for people with large B-cell lymphoma that has spread to the brain or spinal cord and has come back or not responded well to earlier treatments. The first drug, Relma-cel, is a type of immunotherapy that helps your immune system attack cancer cells. The second drug, Tislelizumab, helps keep your immune system active against the cancer.
BeijingAges 18 years+ - NCT05183542Recruiting
Surgery guided by an improved bone scan measurement for back pain
This trial studies whether a more precise bone scan measurement (SPECT/CT) can help guide surgery planning for people with long-lasting lower back pain. It may help surgeons choose and measure the surgery in a more standardized way for certain spine conditions.
Vandœuvre-lès-NancyAges 18 years+ - NCT06789926Recruiting
Support program for oncology nurses
This trial tests a multimedia support platform and a therapy workshop (ACT) to help oncology nurses manage stress and improve their well-being. If you're an oncology nurse, you can join and learn new coping skills.
TaipeiAges 20 years+ - NCT05311072Recruiting
Update a CTEPH patient database in China
This study helps doctors update and improve how they understand chronic thromboembolic pulmonary hypertension (CTEPH) in patients in China. It likely involves sharing your medical information (not a new drug) and confirming your diagnosis details to support future research.
BeijingAges 14 years+ - NCT05305924RecruitingPhase 2
Fulvestrant plus abemaciclib for ER+, HER2− advanced breast cancer
This Phase 2 study tests whether adding abemaciclib to fulvestrant can slow or shrink ER-positive, HER2-negative metastatic breast cancer. It is mainly for people whose cancer has progressed despite prior treatment with a CDK4/6 inhibitor and an aromatase inhibitor.
Houston, TexasAges 18 years+ - NCT06241170Recruiting
Surgical margin study for Crohn's disease recurrence
This trial tests a specific way of cutting the bowel during surgery for Crohn's disease to see if it lowers the chance of the disease coming back. It is for people with Crohn's in the ileocecal area who are having their first surgery to remove that section.
Guangzhou, GuangdongAges 14–65 - NCT05138588Recruiting
rTMS for thinking ups and downs in Lewy body dementia
This study tests whether repeat rTMS sessions can improve thinking “fluctuations” (noticeable ups and downs) in people with Lewy body dementia. It’s a proof-of-concept trial, meaning it’s mainly to see if the approach is feasible and potentially helpful.
StrasbourgAges 45 years+ - NCT02594813Recruiting
Bleeding risk check for endoscopy in people on blood thinners
This trial looks at how often bleeding happens after an upper scope (EGD) or colonoscopy in people who keep taking blood-thinning medicines during the procedure. The results may help doctors choose safer prep plans to lower bleeding risk.
KomaganeAges 20–90
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,623 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.